Clinical Trials on Improve Vulvovaginal Health in Japan

Total 1687 results

Pfizer

Completed

The Study Of Fluconazole For Vulvovaginal Candidiasis

Vulvovaginal Candidiasis

Japan
Cytokinetics

Completed

Pharmacokinetics and Safety Study of Omecamtiv Mecarbil in Healthy Japanese Adults

Healthy Volunteer

Japan
Yoshio Matsui

Unknown

Japan Central Aortic Pressure Prospective Study (J-CARP)

Healthy

Japan
Toujinkai Hospital

Completed

Nicorandil Study to Reduce Cardiac Death After Percutaneous Coronary Intervention (PCI) in Hemodialysis Patients

Congestive Heart Failure | Acute Myocardial Infarction

Japan
Novo Nordisk A/S

Completed

A Research Study Looking at How the Medicine NNC0385-0434 Works in the Body of Healthy Japanese Men

Healthy Volunteers | Atherosclerotic Cardiovascular Disease

Japan
Eli Lilly and Company

Withdrawn

A Study of LY3526318 in Healthy Male Japanese Participants

Healthy

Japan
Janssen Pharmaceutical K.K.

Withdrawn

A Study to Assess the Safety, Pharmacokinetics and Immunogenicity of CR8020 in Japanese Healthy Participants

Healthy

Japan
LEO Pharma

Completed

Dermatopharmacokinetic Trial of LEO 90100 Foam

Healthy

Japan
Janssen Pharmaceutical K.K.

Completed

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Following Subcutaneous Injection of JNJ-64304500 in Healthy Japanese and Caucasian Male Participants

Healthy

Japan
Janssen Pharmaceutical K.K.

Completed

A Study to Evaluate the Pharmacokinetics of Rilpivirine/Tenofovir/Emtricitabine After a Single-Oral Administration in Healthy Japanese Adult Male Participants

Healthy

Japan
Zeria Pharmaceutical

Completed

To Evaluate Pharmacokinetics and Pharmacodynamics of Z-215 in Healthy Male Subjects

Healthy

Japan
LEO Pharma
Quintiles, Inc.

Completed

A Study Evaluating the Safety of LEO 90105 and Its Vehicle, After Multiple Administration on Intact Skin of Healthy Japanese Male Subjects

Healthy

Japan
AstraZeneca

Completed

Assess the Safety, Tolerability and Pharmacokinetics of AZD5213 After Single and Multiple Ascending Oral Doses in Healthy Young and Elderly Japanese Subjects

Healthy

Japan
Nichi-Iko Pharmaceutical Co., Ltd.

Completed

Pharmacokinetics Study of NI-071

Healthy

Japan
Hiroshima University
CHUGOKU KAYAKU CO., LTD.

Completed

Comparison of Absorbability Between Calcium Tablet and Calcium Ion Water

Healthy

Japan
Eisai Co., Ltd.

Completed

E2022 Patch Formulation Multiple Dose Study

Healthy

Japan
Hiroshima University
Unitika Ltd.

Completed

Reduction of the Dietary Glycemic Index (GI) by L-Arabinose and Indigestible Dextrin

Healthy

Japan
AstraZeneca

Completed

Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD2423 Multiple Doses in Healthy Japanese Volunteers

Healthy

Japan
AstraZeneca

Completed

A Study to Assess the Safety, Tolerability and Pharmacokinetics of Modified-Release Formulations of AZD1446 After Oral Single and Repeated Doses

Healthy

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Study Evaluating FXR-450 in Healthy Japanese Men

Healthy

Japan
AstraZeneca

Completed

Study to Assess Safety, Tolerability and Pharmacokinetics After Single and Multiple Doses of AZD1446 to Japanese Subject

Healthy

Japan
Hiroshima University
Hita Tenryosui Co., Ltd.

Completed

Effects of Mineral Water Consumption on Serum Lipid Parameters

Healthy

Japan
Astellas Pharma Inc
Toray Industries, Inc

Completed

Drug-Drug Interaction Study of TRK-100STP

Healthy

Japan
Taisho Pharmaceutical Co., Ltd.
Nagoya University

Completed

Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #1

Healthy Participants

Japan
Kyowa Kirin Co., Ltd.

Completed

A Clinical Pharmacology Study of Bardoxolone Methyl in Healthy Adults

Healthy Subject

Japan
Meiji Seika Pharma Co., Ltd.

Completed

A Phase 1 Pharmacokinetic Bioequivalence Study of DMB-3113 and Adalimumab in Healthy Japanese Adult Male Subjects (DMB-3113-1)

Healthy Volunteer

Japan
Astellas Pharma Inc
FibroGen

Completed

Pharmacokinetic Study of ASP1517 With Kremezin®

Healthy Volunteers

Japan
Eisai Co., Ltd.

Completed

A Study to Assess Safety, Tolerability, and Pharmacokinetics of E2307 in Healthy Young and Elderly Japanese Subjects

Healthy Subjects

Japan
Eli Lilly and Company

Completed

A Study of LY110140 in Healthy Japanese Male Participants

Healthy Volunteer

Japan
Takeda

Completed

A Phase 1, Bioequivalence Study of SYR-472 25mg and 50mg Tablets

Healthy

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Effects of Iron Supplements on the Pharmacokinetics of MT-6548

Healthy

Japan
Hiroshima University

Completed

Effectiveness of Metaverse Space-based Exercise Video Distribution in Young Adults

Healthy

Japan
Janssen Pharmaceutical K.K.

Completed

A Study of JNJ-77242113 in Healthy Japanese and Chinese Participants

Healthy

Japan
Janssen Pharmaceutical K.K.

Completed

A Study of JNJ-61393215 in Healthy Japanese Male Participants

Healthy

Japan
Janssen Pharmaceutical K.K.
Janssen Research & Development, LLC

Terminated

A Study of JNJ-64530440 in Healthy Japanese Male Participants

Healthy

Japan
H. Lundbeck A/S

Completed

Eptinezumab in Healthy Japanese Subjects

Healthy

Japan
Janssen Pharmaceutical K.K.

Completed

A Study of JNJ-63733657 in Healthy Japanese Participants

Healthy

Japan
Janssen Pharmaceutical K.K.

Completed

A Study to Assess the Safety, Tolerability and Pharmacokinetics of Guselkumab Following a Single Intravenous Administration in Healthy Japanese Participants

Healthy

Japan
Janssen Pharmaceutical K.K.

Completed

A Study to Evaluate the Pharmacokinetics (PK) of Darunavir (DRV) and Cobicistat (COBI) After a Single Oral Administration of Darunavir/Cobicistat Fixed-Dose Combination in Healthy Japanese Adult Participants

Healthy

Japan
Janssen Pharmaceutical K.K.

Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-42847922 in Healthy Japanese Male Participants

Healthy

Japan
Janssen Pharmaceutical K.K.

Withdrawn

A Study to Assess the Safety, Pharmacokinetics and Immunogenicity of CR6261 in Japanese Healthy Participants

Healthy

Japan
AstraZeneca

Completed

A Ph1 Study in Healthy Male Japanese and Caucasian After Single and Multiple Doses of D5884(Omega-3-carboxylic Acids)

Healthy

Japan
Fuji Yakuhin Co., Ltd.

Completed

Repeated Dose Phase I Study of FYU-981

Healthy

Japan
Eisai Co., Ltd.

Completed

A Phase 1 Comparative Study of E2022 Current and New Patch Formulations

Healthy

Japan
Janssen Research & Development, LLC

Completed

A Pharmacokinetic Study to Assess the Effect of Food in Healthy Male Participants Receiving TMC435

Healthy

Japan
Hiroshima University

Completed

Database Creation and Evaluation of Motor Function of Finger Tapping Measured by Magnetic Sensor System in Healthy Subjects

Healthy

Japan
AstraZeneca

Completed

AZD0837 Extended Release (ER) Japan Study (ER J ph I)

Healthy

Japan
AstraZeneca

Completed

Study to Investigate Safety and Tolerability Single Ascending Doses of AZD4017.

Healthy

Japan
AstraZeneca

Completed

To Study Safety, Tolerability and Pharmacokinetics of AZD1305 in Healthy Male Japanese Subjects

Healthy

Japan
Fukuoka University

Completed

Investigation of the Effects of Exercise on Gene Expression

Healthy

Japan

3

Subscribe